Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Diabetes. Oct 15, 2022; 13(10): 888-899
Published online Oct 15, 2022. doi: 10.4239/wjd.v13.i10.888
Table 2 Differential metabolites in blood volatile organic carbons of the two groups
Differential metabolite
VIP
P value
Time
FC (GDM/NP)
1-Octyn-3-ol, 4-ethyl-2.27180.0000 9.1501 -0.3956
4-Fluoro-2-trifluoromethylbenzoic acid, cyclohexylmethyl ester1.65880.0000 4.3833 -0.3885
Bicyclo[3.1.0]hexan-3-ol, 4-methyl-1-(1-methylethyl)-2.113170.0000 8.6667 -0.4162
Isolongifolene-5-ol1.858150.0000 18.1917 -0.6099
Oxime-, methoxy-phenyl-1.062880.0001 6.3083 -0.2675
Trans-beta-Ocimene2.013980.0000 6.9250 -0.3406
1H-Pyrazole-1-carbothioamide, 3,5-dimethyl- 1.662390.0000 4.7250 -0.5068
1-Penten-3-one, 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)- 1.382450.0000 18.8000 -0.9345
2-Octen-1-ol, (E)-1.112970.0287 8.0417 0.5487
2-Propanol, 1,1,1-trichloro-2-methyl- 1.328540.0000 7.8167 -0.2366
3,5-Decadien-7-yne, 6-t-butyl-2,2,9,9-tetramethyl- 1.511350.0000 18.7750 -0.5299
3-Heptanol, 5-methyl-1.23840.0001 5.3235 -0.2684
5-Methyluridine, tris(trifluoroacetate)2.049620.0000 10.6833 -0.2948
Hexanal1.097860.0001 4.0858 0.3192
Malonic acid, bis (2-trimethylsilylethyl ester 1.599840.0000 19.5083 -0.3655
Oxalic acid, 2TMS derivative 1.131310.0097 16.6477 0.1542
Quinoxalin-2-one, decahydro-3-(3,3-dimethyl-2-oxobutenylideno)-1.730990.0000 7.3270 -0.0682